SMTL ID : 4bqp.3 (2 other biounits)

Mtb InhA complex with Methyl-thiazole compound 7

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 1.89 Å

Oligo State

homo-tetramer

Ligands

4 x NAD: NICOTINAMIDE-ADENINE-DINUCLEOTIDE(Non-covalent)

NAD.1: 23 residues within 4Å: Chain A: G.14, I.15, I.16, S.20, I.21, F.41, L.63, D.64, V.65, S.94, I.95, G.96, I.122, M.147, D.148, F.149, K.165, A.191, G.192, P.193, I.194, T.196 Ligands: VMY.2 17 PLIP interactions: 17 interactions with chain A Hydrophobic interactions: A:I.21, A:F.149, A:A.191 Hydrogen bonds: A:G.14, A:G.14, A:I.21, A:D.64, A:V.65, A:I.95, A:G.96, A:K.165, A:I.194, A:I.194 Water bridges: A:G.14, A:S.94, A:I.95 pi-Stacking: A:F.41 NAD.3: 24 residues within 4Å: Chain B: G.14, I.15, I.16, S.20, I.21, F.41, L.63, D.64, V.65, S.94, I.95, G.96, I.122, M.147, D.148, F.149, M.161, K.165, A.191, G.192, P.193, I.194, T.196 Ligands: VMY.4 16 PLIP interactions: 16 interactions with chain B Hydrophobic interactions: B:F.149, B:A.191 Hydrogen bonds: B:G.14, B:S.20, B:I.21, B:D.64, B:V.65, B:I.95, B:G.96, B:K.165, B:I.194, B:I.194, B:T.196, B:T.196 Water bridges: B:F.41 pi-Stacking: B:F.41 NAD.5: 24 residues within 4Å: Chain C: G.14, I.15, I.16, S.20, I.21, F.41, L.63, D.64, V.65, S.94, I.95, G.96, I.122, M.147, D.148, F.149, K.165, A.191, G.192, P.193, I.194, T.196, M.199 Ligands: VMY.6 20 PLIP interactions: 20 interactions with chain C Hydrophobic interactions: C:I.21, C:F.149, C:A.191 Hydrogen bonds: C:G.14, C:S.20, C:I.21, C:D.64, C:D.64, C:V.65, C:I.95, C:G.96, C:K.165, C:I.194, C:T.196, C:T.196 Water bridges: C:A.22, C:F.41, C:I.95, C:T.196 pi-Stacking: C:F.41 NAD.7: 24 residues within 4Å: Chain D: G.14, I.15, I.16, S.20, I.21, F.41, L.63, D.64, V.65, S.94, I.95, G.96, I.122, M.147, D.148, F.149, K.165, A.191, G.192, P.193, I.194, T.196, M.199 Ligands: VMY.8 18 PLIP interactions: 18 interactions with chain D Hydrophobic interactions: D:I.21, D:F.149 Hydrogen bonds: D:G.14, D:I.21, D:D.64, D:D.64, D:V.65, D:I.95, D:G.96, D:K.165, D:I.194, D:I.194, D:T.196, D:T.196 Water bridges: D:A.22, D:F.41, D:I.95 pi-Stacking: D:F.41

4 x VMY: (1S)-1-(5-{[1-(2,6-DIFLUOROBENZYL)-1H-PYRAZOL-3-YL]AMINO}-1,3,4-THIADIAZOL-2-YL)-1-(4-METHYL-1,3-THIAZOL-2-YL)ETHANOL(Non-covalent)

VMY.2: 11 residues within 4Å: Chain A: G.96, F.97, M.98, Q.100, M.103, G.104, F.149, Y.158, M.161, L.207 Ligands: NAD.1 6 PLIP interactions: 6 interactions with chain A Hydrophobic interactions: A:Q.100, A:M.103, A:F.149 Hydrogen bonds: A:M.98, A:M.98 pi-Stacking: A:Y.158 VMY.4: 11 residues within 4Å: Chain B: G.96, F.97, M.98, M.103, G.104, F.149, A.157, Y.158, M.161, K.165 Ligands: NAD.3 5 PLIP interactions: 5 interactions with chain B Hydrophobic interactions: B:F.149, B:A.157 Hydrogen bonds: B:M.98, B:M.98 pi-Stacking: B:Y.158 VMY.6: 13 residues within 4Å: Chain C: G.96, F.97, M.98, M.103, G.104, F.149, Y.158, M.161, A.198, M.199, I.202, I.215 Ligands: NAD.5 9 PLIP interactions: 9 interactions with chain C Hydrophobic interactions: C:M.103, C:F.149, C:I.202, C:I.215 Hydrogen bonds: C:M.98, C:M.98 Water bridges: C:T.196, C:A.198 pi-Stacking: C:Y.158 VMY.8: 15 residues within 4Å: Chain D: G.96, F.97, M.98, Q.100, M.103, G.104, F.149, A.157, Y.158, M.161, A.198, M.199, L.207, I.215 Ligands: NAD.7 7 PLIP interactions: 7 interactions with chain D Hydrophobic interactions: D:Q.100, D:F.149, D:A.157, D:I.215 Hydrogen bonds: D:M.98, D:M.98 pi-Stacking: D:Y.158

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Shirude, P.S. et al., Methyl-Thiazoles: A Novel Mode of Inhibition with the Potential to Develop Novel Inhibitors Targeting Inha in Mycobacterium Tuberculosis. J.Med.Chem. (2013)

Release Date

2013-12-11

Peptides

ENOYL-[ACYL-CARRIER-PROTEIN] REDUCTASE [NADH]: ABCD

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
E

B
F

C
C

D
D

ENOYL-[ACYL-CARRIER-PROTEIN] REDUCTASE [NADH]

Related Entries With Identical Sequence